Randomised, controlled multicentre-trial for the optimised therapy of the acutely ischaemic limb with controlled reperfusion

ISRCTN ISRCTN29807122
DOI https://doi.org/10.1186/ISRCTN29807122
ClinicalTrials.gov (NCT) NCT00567801
Clinical Trials Information System (CTIS) Nil known
Protocol serial number S 991228
Sponsor University Hospital Freiburg (Germany)
Funders Deutsche Forschungsgemeinschaft, Bonn, Germany, Dr. Köhler-Chemie, Alsbach-Hähnlein, Germany, Local research commission, University hospital Freiburg, Germany
Submission date
22/03/2004
Registration date
15/04/2004
Last edited
31/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Friedhelm Beyersdorf
Scientific

Department of Cardiovascular Surgery
University Hospital Freiburg
Hugstetterstr. 55
Freiburg
79106
Germany

Phone +49 761 2702818
Email beyers@chir.ukl.uni-freiburg.de

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleRandomised, controlled multicentre-trial for the optimised therapy of the acutely ischaemic limb with controlled reperfusion
Study acronymCRAIL
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedAcutely ischaemic limb
InterventionEmbolectomy/Thrombectomy vs controlled reperfusion after Embolectomy/Thrombectomy
Intervention typeOther
Primary outcome measure(s)

Not provided at time of registration

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexNot Specified
Total final enrolment174
Key inclusion criteria1. Patient >18 years
2. Acute arterial occlusion of one or both lower limbs (Rutherford IIa-III)
Key exclusion criteria1. Patients having undergone an attempt at recanalisation (Lyse etc.)
2. Heart failure (New York Heart Association [NYHA] IV)
3. Terminal kidney failure
4. Patients with a known aneurysm of the arteria poplitea
Date of first enrolment01/01/2004
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • Germany

Study participating centre

Department of Cardiovascular Surgery
Freiburg
79106
Germany

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2013 31/05/2019 Yes No
Other publications preliminary study 01/10/2005 Yes No

Editorial Notes

31/05/2019: The following changes were made:
1. Publication reference added.
2. Total final enrolment added.
3. Clinicaltrials.gov number added.